glp-1 hers reviews Despite the Stigma, Hims & Isn't Backing Away From Weight-Loss Drugs Hers weight loss review 2026

The prospective observational study called Sulfonamide Allergies and Outcomes Related to the Use of Potentially Cross-reactive Drugs in Hospitalized Patients reports that patients who have allergic reactions to a sulfonamide have a low risk of cross-reactive allergic reaction and are able to receive sulfonamide nonantimicrobial agents

224 : 8386 Rosenthal RE, Williams R, Bogaert YE, Getson PR, Fiskum G

A major growth catalyst was the FDA approval of Dupixent as the first biologic treatment for chronic obstructive pulmonary disease (COPD) with an eosinophilic phenotype, opening a new market segment

Harmful cyanobacterial bloom control with hydrogen peroxide: mechanism, affecting factors, development, and prospects

Dipeptidyl peptidase-4 inhibition in patients with type 2 diabetes treated with saxagliptin, sitagliptin, or vildagliptin